Description

Syncona Limited operates as an investment fund, strategically deploying capital across a broad spectrum of investment vehicles, including hedge funds, equity funds, and long-duration alternative investments, spanning numerous asset classes. The firm actively oversees portfolios dedicated to private equity, debt instruments, fixed income securities, and various other alternative strategies. A significant portion of its focus is directed towards the healthcare and life sciences sectors, with particular interest in advancements such as cell therapy, gene therapy, biologics, and small molecules. Syncona's global reach extends to both public equity and fixed-income markets. Its core objective is to generate compelling medium to long-term returns by identifying and investing in leading long-only and alternative investment funds led by experienced managers, typically through separately managed account portfolios, to execute these multi-asset class strategies.